239 related articles for article (PubMed ID: 33512383)
1. Notch signaling promotes disease initiation and progression in murine chronic lymphocytic leukemia.
Tardivon D; Antoszewski M; Zangger N; Nkosi M; Sordet-Dessimoz J; Hendriks R; Koch U; Radtke F
Blood; 2021 Jun; 137(22):3079-3092. PubMed ID: 33512383
[TBL] [Abstract][Full Text] [Related]
2. Activation of
Biran A; Yin S; Kretzmer H; Ten Hacken E; Parvin S; Lucas F; Uduman M; Gutierrez C; Dangle N; Billington L; Regis FF; Rassenti LZ; Mohammad A; Hoffmann GB; Stevenson K; Zheng M; Witten E; Fernandes SM; Tausch E; Sun C; Stilgenbauer S; Brown JR; Kipps TJ; Aster JC; Gnirke A; Neuberg DS; Letai A; Wang L; Carrasco RD; Meissner A; Wu CJ
Cancer Res; 2021 Dec; 81(24):6117-6130. PubMed ID: 34686499
[TBL] [Abstract][Full Text] [Related]
3. Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.
Riches JC; O'Donovan CJ; Kingdon SJ; McClanahan F; Clear AJ; Neuberg DS; Werner L; Croce CM; Ramsay AG; Rassenti LZ; Kipps TJ; Gribben JG
Blood; 2014 Jun; 123(26):4101-10. PubMed ID: 24829201
[TBL] [Abstract][Full Text] [Related]
4. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
6. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
[TBL] [Abstract][Full Text] [Related]
7. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
8. MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
Wu B; Słabicki M; Sellner L; Dietrich S; Liu X; Jethwa A; Hüllein J; Walther T; Wagner L; Huang Z; Zapatka M; Zenz T
Br J Haematol; 2017 Nov; 179(3):421-429. PubMed ID: 28771672
[TBL] [Abstract][Full Text] [Related]
9. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
10. Common nonmutational
Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
[TBL] [Abstract][Full Text] [Related]
11. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
Del Papa B; Baldoni S; Dorillo E; De Falco F; Rompietti C; Cecchini D; Cantelmi MG; Sorcini D; Nogarotto M; Adamo FM; Mezzasoma F; Silva Barcelos EC; Albi E; Iacucci Ostini R; Di Tommaso A; Marra A; Montanaro G; Martelli MP; Falzetti F; Di Ianni M; Rosati E; Sportoletti P
Clin Cancer Res; 2019 Dec; 25(24):7540-7553. PubMed ID: 31578228
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.
De Falco F; Sabatini R; Del Papa B; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Screpanti I; Marconi P; Rosati E
Oncotarget; 2015 Jun; 6(18):16559-72. PubMed ID: 26041884
[TBL] [Abstract][Full Text] [Related]
13. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways?
Seke Etet PF; Vecchio L; Nwabo Kamdje AH
Cell Signal; 2012 Jul; 24(7):1433-43. PubMed ID: 22446006
[TBL] [Abstract][Full Text] [Related]
14. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
[TBL] [Abstract][Full Text] [Related]
15. Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.
Shukla V; Shukla A; Joshi SS; Lu R
Oncotarget; 2016 Jul; 7(27):41081-41094. PubMed ID: 27232759
[TBL] [Abstract][Full Text] [Related]
16. [Expression of Notch Gene and Its Role of Anti-apoptosis and Drug-resistance of Cells in Chronic Lymphocytic Leukemia].
Zhang JY; Zhang JS; Xu ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):919-24. PubMed ID: 26314418
[TBL] [Abstract][Full Text] [Related]
17.
Close V; Close W; Kugler SJ; Reichenzeller M; Yosifov DY; Bloehdorn J; Pan L; Tausch E; Westhoff MA; Döhner H; Stilgenbauer S; Oswald F; Mertens D
Blood; 2019 Feb; 133(8):830-839. PubMed ID: 30510140
[No Abstract] [Full Text] [Related]
18. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Baldoni S; Del Papa B; Dorillo E; Aureli P; De Falco F; Rompietti C; Sorcini D; Varasano E; Cecchini D; Zei T; Di Tommaso A; Rosati E; Alexe G; Roti G; Stegmaier K; Di Ianni M; Falzetti F; Sportoletti P
Int J Cancer; 2018 Aug; 143(4):958-970. PubMed ID: 29508386
[TBL] [Abstract][Full Text] [Related]
19. Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
Gutjahr JC; Szenes E; Tschech L; Asslaber D; Schlederer M; Roos S; Yu X; Girbl T; Sternberg C; Egle A; Aberger F; Alon R; Kenner L; Greil R; Orian-Rousseau V; Hartmann TN
Blood; 2018 Mar; 131(12):1337-1349. PubMed ID: 29352038
[TBL] [Abstract][Full Text] [Related]
20. Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.
Zhang Q; Zhu Z; Guan J; Hu Y; Zhou W; Ye W; Lin B; Weng S; Chen Y; Zheng C
Mol Biotechnol; 2022 Dec; 64(12):1419-1430. PubMed ID: 35704163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
